P53 AND BCL-2 IMMUNOHISTOCHEMISTRY IN PRETREATMENT PROSTATE NEEDLE BIOPSIES TO PREDICT RECURRENCE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
- 1 December 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 162 (6) , 2040-2045
- https://doi.org/10.1016/s0022-5347(05)68095-0
Abstract
Purpose: Immunohistochemical staining of radical prostatectomy specimens for p53 and bcl-2 proteins has been shown to correlate with prostate specific antigen (PSA) recurrence in a series of patien...Keywords
This publication has 26 references indexed in Scilit:
- COMBINED ANALYSIS WITH BCL-2 AND P53 IMMUNOSTAINING PREDICTS POORER PROGNOSIS IN PROSTATIC CARCINOMAJournal of Urology, 1997
- Screening for prostate cancerThe Lancet, 1997
- CLINICAL GUIDELINES: PART II: Early Detection of Prostate Cancer: Part IIAnnals of Internal Medicine, 1997
- Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate CancerJournal of Urology, 1996
- Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate CancerJournal of Urology, 1994
- The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical ProstatectomyJournal of Urology, 1994
- The Prostate Cancer Intervention Versus Observation Trial: A Randomized Trial Comparing Radical Prostatectomy Versus Expectant Management for the Treatment of Clinically Localized Prostate CancerJournal of Urology, 1994
- 5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate CancerJournal of Urology, 1994
- Impact of Radical Prostatectomy in the Management of Clinically Localized DiseaseJournal of Urology, 1994
- National Patterns of Prostate Cancer Treatment by Radical Prostatectomy: Results of a Survey by the American College of Surgeons Commission on CancerJournal of Urology, 1994